KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Convertible Debt (2020 - 2025)

Historic Convertible Debt for Neogenomics (NEO) over the last 6 years, with Q3 2025 value amounting to $341.5 million.

  • Neogenomics' Convertible Debt rose 44.71% to $341.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.5 million, marking a year-over-year increase of 44.71%. This contributed to the annual value of $340.3 million for FY2024, which is 3676.4% down from last year.
  • Latest data reveals that Neogenomics reported Convertible Debt of $341.5 million as of Q3 2025, which was up 44.71% from $341.1 million recorded in Q2 2025.
  • Neogenomics' 5-year Convertible Debt high stood at $538.9 million for Q1 2024, and its period low was $339.6 million during Q2 2024.
  • Moreover, its 5-year median value for Convertible Debt was $532.5 million (2021), whereas its average is $473.3 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first surged by 22275.68% in 2021, then plummeted by 3677.87% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Convertible Debt stood at $532.5 million in 2021, then rose by 0.53% to $535.3 million in 2022, then rose by 0.54% to $538.2 million in 2023, then crashed by 36.76% to $340.3 million in 2024, then grew by 0.34% to $341.5 million in 2025.
  • Its Convertible Debt was $341.5 million in Q3 2025, compared to $341.1 million in Q2 2025 and $340.7 million in Q1 2025.